These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8198390)

  • 21. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?
    Montagnani Marelli M; Moretti RM; Januszkiewicz-Caulier J; Motta M; Limonta P
    Curr Cancer Drug Targets; 2006 May; 6(3):257-69. PubMed ID: 16712461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical applications of gonadotropin-releasing hormones in reproductive disorders.
    Moghissi KS
    Endocrinol Metab Clin North Am; 1992 Mar; 21(1):125-40. PubMed ID: 1576979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diversity of actions of GnRHs mediated by ligand-induced selective signaling.
    Millar RP; Pawson AJ; Morgan K; Rissman EF; Lu ZL
    Front Neuroendocrinol; 2008 Jan; 29(1):17-35. PubMed ID: 17976709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analogs of gonadoliberin. Value in physiology and therapeutics].
    Charbonnel B
    Presse Med; 1994 Apr 30-May 7; 23(17):805-11. PubMed ID: 8078839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin-releasing-hormone-receptor antagonists.
    Huirne JA; Lambalk CB
    Lancet; 2001 Nov; 358(9295):1793-803. PubMed ID: 11734258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of pituitary gonadotropin-releasing hormone receptors by pulsatile gonadotropin-releasing hormone injections in male rats. Modulation by testosterone.
    Garcia A; Schiff M; Marshall JC
    J Clin Invest; 1984 Sep; 74(3):920-8. PubMed ID: 6088587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GnRH agonists and antagonists in cancer therapy.
    Chengalvala MV; Pelletier JC; Kopf GS
    Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):399-410. PubMed ID: 14529448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin-releasing hormone agonists. Current uses for these increasingly important drugs.
    Winkel CA
    Postgrad Med; 1994 May; 95(6):111-8. PubMed ID: 8170869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadotropin-releasing hormone in the ovary.
    Metallinou C; Asimakopoulos B; Schröer A; Nikolettos N
    Reprod Sci; 2007 Dec; 14(8):737-49. PubMed ID: 18089592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous human metastin 45-54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications.
    Seminara SB; Dipietro MJ; Ramaswamy S; Crowley WF; Plant TM
    Endocrinology; 2006 May; 147(5):2122-6. PubMed ID: 16469799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GnRH agonists: gonadorelin, leuprolide and nafarelin.
    Pace JN; Miller JL; Rose LI
    Am Fam Physician; 1991 Nov; 44(5):1777-82. PubMed ID: 1835275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of the hypothalamic-pituitary-gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice.
    Nakata D; Masaki T; Tanaka A; Yoshimatsu M; Akinaga Y; Asada M; Sasada R; Takeyama M; Miwa K; Watanabe T; Kusaka M
    Eur J Pharmacol; 2014 Jan; 723():167-74. PubMed ID: 24333551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luteinizing hormone releasing hormone analogues for contraception.
    Nillius SJ
    Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.
    Finkelstein JS; Whitcomb RW; O'Dea LS; Longcope C; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1991 Sep; 73(3):609-20. PubMed ID: 1908484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.
    Kim SM; Yoo T; Lee SY; Kim EJ; Lee SM; Lee MH; Han MY; Jung SH; Choi JH; Ryu KH; Kim HT
    Life Sci; 2015 Oct; 139():166-74. PubMed ID: 26321528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical uses of gonadotropin-releasing hormone analogues.
    Casper RF
    CMAJ; 1991 Jan; 144(2):153-8. PubMed ID: 1986827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotropin-releasing hormone analog therapeutics.
    Newton CL; Riekert C; Millar RP
    Minerva Ginecol; 2018 Oct; 70(5):497-515. PubMed ID: 30264955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications.
    Millar RP; Zhu YF; Chen C; Struthers RS
    Br Med Bull; 2000; 56(3):761-72. PubMed ID: 11255560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA recommendations for preclinical testing of gonadotropin releasing hormone (GnRH) analogues.
    Raheja KL; Jordan A
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):168-75. PubMed ID: 8041914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gonadotropin releasing hormones. Clinical applications in gynecology.
    Moghissi KS
    J Reprod Med; 1990 Dec; 35(12):1097-107. PubMed ID: 2283627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.